C-mo Medical Solutions
C-mo Medical Solutions makes C-mo System, a CE-marked wearable cough monitor that measures cough frequency and intensity for clinical trials.
C-mo Medical Solutions makes C-mo System, a CE-marked wearable cough monitor that measures cough frequency and intensity for clinical trials.
C-mo's proprietary technology activates its microphone only during cough events, so it avoids recording private conversations, a privacy protection the company presents as a first for cough monitoring. Patients can exercise and shower while wearing it, letting monitoring follow normal daily routines.
The wearable is ergonomic enough that patients report forgetting they wear it within minutes. Fully automated analysis removes manual cough counting and gives physicians objective frequency and intensity data.
Source: c-mo.solutions
Chronic cough affects about 700 million adults worldwide, and 98.5% of respiratory doctors say they need objective data on their patients' cough. The European Respiratory Society has called for fully automated, continuous cough recording technology.
Cough remains highly subjective for patients and is not yet used as a clinical biomarker, leaving a gap for objective measurement. Conditions such as asthma, COPD, ILD, GERD, and bronchiectasis all present cough, widening the potential clinical demand.
Source: c-mo.solutions
C-mo Medical Solutions addresses an unmet need: cough is the most common respiratory symptom, yet clinicians lack an objective way to measure it. Its C-mo System wearable automates cough frequency and intensity analysis over multi-day monitoring.
Privacy-preserving recording and routine-friendly wear differentiate the device for long-term use. Clinical validation so far covers monitoring periods of up to 24 hours, so extending validated duration and adding planned assessment features are the next proof points.
Source: c-mo.solutions
C-mo Medical Solutions makes C-mo System, a wearable cough monitor that records cough continuously and analyses it automatically. It measures cough frequency and intensity and delivers results to clinicians as intuitive reports.
The device serves respiratory care, where cough is a key symptom of asthma, COPD, ILD, GERD, and bronchiectasis yet lacks objective assessment. A single charge supports up to three days of continuous monitoring.
Source: c-mo.solutions